Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Gastroenterology | Infections and Infectious Diseases | Family Medicine
Disease Category: Clostridium Difficile-Associated Diarrhea
Location: United States, NY
Let’s Try to Break the Cycle
If a patient has C. diff now, they have up to a 60% chance of having C. diff again.*
The MODIFY Study in testing the safety, effectiveness and tolerability of an investigational drug to see if it can help prevent C. diff reoccurrences.
Participants will receive study-related exams and study drug at no charge. There are risks associated with participation in this clinical research study. They study doctor will explain the study requirements, possible benefits, and potential risks to you before you decide to participate.
Patient Inclusion Criteria:
Eligible participants must:
- Be at least 18 years of age
- Have a diagnosis of C. diff (including a positive stool test)
Lorraine Breuer, Vice President for Research
Parker Jewish Institute
271-11 76th Avenue
New Hyde Park, NY 11040
Research Center Information: Parker Jewish Institute
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these